Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Coronapod: Dexamethasone, the cheap steroid that could cut coronavirus deaths

Coronapod: Dexamethasone, the cheap steroid that could cut coronavirus deaths

FromNature Podcast


Coronapod: Dexamethasone, the cheap steroid that could cut coronavirus deaths

FromNature Podcast

ratings:
Length:
38 minutes
Released:
Jun 19, 2020
Format:
Podcast episode

Description

In this episode:00:37 Lessons from the Ebola outbreakWe get an update on the pandemic response in the African countries still reeling from the 2014 Ebola crisis. Resource strapped and under pressure – can the lessons learned from Ebola help keep the coronavirus under control?15:32 Dexamethasone, a breakthrough drug?A UK-based drugs trial suggests that a cheap steroid could cut deaths by a third among the sickest COVID patients. We discuss what this could mean for the pandemic.News: Coronavirus breakthrough: dexamethasone is first drug shown to save lives20:06 One good thingOur hosts pick out things that have made them smile in the last week, including altruistic bone marrow donors, and skateboarding.22:48 The numbers don’t lieA huge amount of projections, graphs and data have been produced during the pandemic. But how accurate are numbers and can they be relied upon?News: Why daily death tolls have become unusually important in understanding the coronavirus pandemicSubscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.
 See acast.com/privacy for privacy and opt-out information.
Released:
Jun 19, 2020
Format:
Podcast episode

Titles in the series (100)

The Nature Podcast brings you the best stories from the world of science each week. We cover everything from astronomy to zoology, highlighting the most exciting research from each issue of Nature journal. We meet the scientists behind the results and providing in-depth analysis from Nature's journalists and editors.